Profitability Ratios
| Ratio |
Value |
| GP Margin |
0.0% |
| EBIT Margin |
0.0% |
| EBITDA Margin |
0.0% |
| Operating Margin |
0.0% |
| Pretax Margin |
0.0% |
| Cont. Ops Margin |
0.0% |
| Net Margin |
0.0% |
| Bottom Line Margin |
0.0% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
0.76 |
| Quick Ratio |
0.76 |
| Solvency Ratio |
-1.590 |
| Cash Ratio |
0.36 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.10 |
| Forward PEG |
-0.10 |
| Price/Book |
1694.63 |
| Price/Sales |
0.00 |
| Price/FCF |
-6.85 |
| Price/Op Cash Flow |
-6.86 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0397 |
| Debt/Equity |
8.7692 |
| Debt/Capital |
0.8976 |
| Long-Term Debt/Capital |
0.0000 |
| Financial Leverage |
221.06 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
0.00 |
| Operating Cash Flow Ratio |
-1.146 |
| Operating Cash Flow/Sales |
0.0% |
| Free Cash Flow/Operating Cash Flow |
100.2% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
-1009.94 |
| Interest Coverage |
-1174.0000 |
| Short-Term Operating Cash Flow Coverage |
0.00 |
| Operating Cash Flow Coverage |
-28.17 |
| Capital Expenditure Coverage |
-611.76 |
| Dividend + Capital Expenditure Coverage |
-611.76 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
0.00 |
| EPS |
-0.312 |
| Debt/Share |
0.0080 |
| Cash/Share |
0.07 |
| Book Value/Share |
0.00 |
| Tangible BV/Share |
0.00 |
| Equity/Share |
0.00 |
| Operating Cash Flow/Share |
-0.217 |
| Capital Expenditure/Share |
0.000 |
| FCF/Share |
-0.218 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.000 |
| Earnings Before Tax/EBIT |
0.872 |
| Price/Fair Value |
1694.63 |
| Debt/Market Cap |
0.0000 |
| Effective Tax Rate |
0.0% |
| Enterprise Value Multiple |
-4.65 |
TLSA - Tiziana Life Sciences Ltd